Piramal Pharma Ltd. — documents
75 files on disk. SHA-256 from the acquisition manifests; links open the exchange copy.
| Class | Period | Scope / kind | Filing date | File | SHA-256 |
|---|---|---|---|---|---|
| Results XBRL (NSE) | 2022-09-30 | Standalone | — | INDAS_854422_6941_10112022165302_WEB.xml | 3171f0171a0df0b6 |
| Results XBRL (NSE) | 2022-09-30 | Consolidated | — | INDAS_854434_6941_10112022165349_WEB.xml | 5b1298356adece2c |
| Results XBRL (NSE) | 2022-12-31 | Standalone | — | INDAS_89090_789310_09022023123946.xml | 27f2173c38ba99e4 |
| Results XBRL (NSE) | 2022-12-31 | Consolidated | — | INDAS_89091_789314_09022023124053.xml | 2792cd05ece12337 |
| Results XBRL (NSE) | 2023-03-31 | Standalone | — | INDAS_92612_851834_25052023034953.xml | e9ffce829f54833d |
| Results XBRL (NSE) | 2023-03-31 | Consolidated | — | INDAS_92615_851845_25052023035236.xml | 1c0b4ead10ceb77d |
| Results XBRL (NSE) | 2023-06-30 | Consolidated | — | INDAS_95272_907677_03082023092949.xml | bf866c1b03a08d07 |
| Results XBRL (NSE) | 2023-06-30 | Standalone | — | INDAS_95273_907680_03082023093140.xml | 8fbd86a575c9ca81 |
| Results XBRL (NSE) | 2023-09-30 | Standalone | — | INDAS_98159_970125_28102023044125.xml | d81f766f1c92f6c7 |
| Results XBRL (NSE) | 2023-09-30 | Consolidated | — | INDAS_98161_970133_28102023044311.xml | c7f66ee9d7325b36 |
| Results XBRL (NSE) | 2023-12-31 | Standalone | — | INDAS_101798_1039652_30012024091308.xml | afbdc087cc93dcdf |
| Results XBRL (NSE) | 2023-12-31 | Consolidated | — | INDAS_101799_1039657_30012024091425.xml | 73749b9205d38c88 |
| Results XBRL (NSE) | 2024-03-31 | Standalone | — | INDAS_105677_1120742_10052024092259.xml | 74f7e8c2b339ed4c |
| Results XBRL (NSE) | 2024-03-31 | Consolidated | — | INDAS_105678_1120745_10052024092427.xml | 1c344f6679feec1c |
| Results XBRL (NSE) | 2024-06-30 | Standalone | — | INDAS_109533_1203138_26072024125922.xml | e3efb3839c36e8a6 |
| Results XBRL (NSE) | 2024-06-30 | Consolidated | — | INDAS_109536_1203146_26072024010031.xml | 056f66b2a8453ddd |
| Results XBRL (NSE) | 2024-09-30 | Standalone | — | INDAS_113140_1286528_23102024082726.xml | cb2958d1e7d3650d |
| Results XBRL (NSE) | 2024-09-30 | Consolidated | — | INDAS_113141_1286531_23102024082948.xml | dd53fed85ec19fa6 |
| Results XBRL (NSE) | 2024-12-31 | Standalone | — | INDAS_117924_1363798_28012025090302.xml | c39af87297b7b3f4 |
| Results XBRL (NSE) | 2024-12-31 | Consolidated | — | INDAS_117925_1363802_28012025090457.xml | 1313c895b9ba3a48 |
| Results XBRL (NSE) | 2025-03-31 | Standalone | — | INTEGRATED_FILING_INDAS_1439217_14052025 | 2d4fbbf156287cd8 |
| Results XBRL (NSE) | 2025-03-31 | Consolidated | — | INTEGRATED_FILING_INDAS_1439218_14052025 | 9d5c017fb7394d36 |
| Results XBRL (NSE) | 2025-06-30 | Standalone | — | INTEGRATED_FILING_INDAS_1495855_28072025 | af02e8da9a18ce43 |
| Results XBRL (NSE) | 2025-06-30 | Consolidated | — | INTEGRATED_FILING_INDAS_1495857_28072025 | b007e14384b30066 |
| Results XBRL (NSE) | 2025-09-30 | Standalone | — | INTEGRATED_FILING_INDAS_1566229_05112025 | 62eb8799642191b8 |
| Results XBRL (NSE) | 2025-09-30 | Consolidated | — | INTEGRATED_FILING_INDAS_1566230_05112025 | a40367626aefeed5 |
| Results XBRL (NSE) | 2025-12-31 | Consolidated | — | INTEGRATED_FILING_INDAS_1614519_30012026 | 1f0653fbb62463a9 |
| Results XBRL (NSE) | 2025-12-31 | Standalone | — | INTEGRATED_FILING_INDAS_1614524_30012026 | 85ab851c0c9bdab4 |
| Results XBRL (NSE) | 2026-03-31 | Standalone | — | INTEGRATED_FILING_INDAS_1660700_28042026 | ad8a74baa606fb46 |
| Results XBRL (NSE) | 2026-03-31 | Consolidated | — | INTEGRATED_FILING_INDAS_1660701_28042026 | e15d649460eb2776 |
| Results XBRL (NSE) | 2026-06-30 | Standalone | — | INTEGRATED_FILING_INDAS_1704574_29072026 | bd9c90d029c2f2b0 |
| Results XBRL (NSE) | 2026-06-30 | Consolidated | — | INTEGRATED_FILING_INDAS_1704575_29072026 | 68da2b880e995127 |
| Results XBRL (BSE) | 2022-09-30 | Standalone | 2022-11-22T10:13:55 | Main_Ind_As_543635_9112022173242.xml | 3171f0171a0df0b6 |
| Results XBRL (BSE) | 2022-09-30 | Consolidated | 2022-11-22T10:13:55 | Main_Ind_As_543635_9112022173511.xml | 5b1298356adece2c |
| Annual report | 2023-03-31 | grade A | 2023-07-06T20:38:35.867 | 73a532ba-6b75-4bf8-a1b1-469e19ecf065.pdf | 077769322794269a |
| Annual report | 2024-03-31 | grade A | 2024-07-02T15:08:16.72 | c09d72ec-f184-4eba-bcc8-93b26b846609.pdf | 653081c5025dcaa0 |
| Annual report | 2025-03-31 | grade A | 2025-07-02T12:52:53.91 | 33c9f38c-0692-4e04-b789-77605f82aa29.pdf | aefc4627a5b75fd9 |
| Annual report | 2026-03-31 | grade A | 2026-07-03T15:31:30.04 | 8a3aabd8-6aef-45b8-aa20-370bc162321a.pdf | c4e6c5db46ca896a |
| Concall | 2022-09-30 | TRANSCRIPT | — | Date_20221111_Piramal Pharma Ltd._Concal_Q2FY23.pdf | 1c7528231b1e4bd7 |
| Concall | 2022-12-31 | TRANSCRIPT | — | Date_20230213_Piramal Pharma Ltd._Concal_Q3FY23.pdf | c4d6fcbb25f26c39 |
| Concall | 2023-03-31 | TRANSCRIPT | — | Date_20230518_Piramal Pharma Ltd._Concal_Q4FY23.pdf | b04dc03f5e02df3d |
| Concall | 2023-03-31 | COVER_LETTER | — | Date_20230529_Piramal Pharma Ltd._Concal_Q4FY23.pdf | a00753f9fb95f74e |
| Concall | 2023-06-30 | TRANSCRIPT | — | Date_20230807_Piramal Pharma Ltd._Concal_Q1FY24.pdf | fbcffd152e988822 |
| Concall | 2023-09-30 | COVER_LETTER | — | Date_20231031_Piramal Pharma Ltd._Concal_Q2FY24.pdf | 0e24354c9dc55a81 |
| Concall | 2023-12-31 | COVER_LETTER | — | Date_20240202_Piramal Pharma Ltd._Concal_Q3FY24.pdf | cb70131b1942ab36 |
| Concall | 2024-03-31 | COVER_LETTER | — | Date_20240514_Piramal Pharma Ltd._Concal_Q4FY24.pdf | 1b0f32e9f9b44135 |
| Concall | 2024-06-30 | COVER_LETTER | — | Date_20240729_Piramal Pharma Ltd._Concal_Q1FY25.pdf | f7b15f05c62c238d |
| Concall | 2024-09-30 | COVER_LETTER | — | Date_20241026_Piramal Pharma Ltd._Concal_Q2FY25.pdf | 3a992c014699c281 |
| Concall | 2024-12-31 | COVER_LETTER | — | Date_20250130_Piramal Pharma Ltd._Concal_Q3FY25.pdf | 739025945684014c |
| Concall | 2025-09-30 | COVER_LETTER | — | Date_20251107_Piramal Pharma Ltd._Concal_Q2FY26.pdf | 5ed8da6e83ebcf29 |
| Concall | 2025-12-31 | COVER_LETTER | — | Date_20260130_Piramal Pharma Ltd._Concal_Q3FY26.pdf | ddbdb98fd1b43fc2 |
| Concall | 2026-06-30 | COVER_LETTER | — | Date_20260731_Piramal Pharma Ltd._Concal_Q1FY27.pdf | 07e9e6cbae713e3b |
| Shareholding XBRL | 2022-10-19 | — | — | SHP_173244_744393_03112022042913_WEB.xml | 5d8175c8f826249d |
| Shareholding XBRL | 2022-12-31 | — | — | SHP_175248_775051_20012023033233_WEB.xml | 9efa2130166b04c3 |
| Shareholding XBRL | 2023-03-31 | — | — | SHP_177891_829789_21042023121401_WEB.xml | d3361cc4c5395831 |
| Shareholding XBRL | 2023-06-30 | — | — | SHP_179557_891245_18072023080737_WEB.xml | 5d91f2628e99b3fa |
| Shareholding XBRL | 2023-08-22 | — | — | SHP_180405_922768_25082023015028_WEB.xml | 170d7e4a37646a81 |
| Shareholding XBRL | 2023-09-27 | — | — | SHP_180631_941763_06102023052210_WEB.xml | 94878aac940ca8db |
| Shareholding XBRL | 2023-09-30 | — | — | SHP_182352_959877_19102023021617_WEB.xml | b5ae8440e96ef0f7 |
| Shareholding XBRL | 2023-12-31 | — | — | SHP_185084_1030201_19012024060525_WEB.xm | c5eff8b351004e01 |
| Shareholding XBRL | 2024-03-31 | — | — | SHP_187890_1101499_19042024050025_WEB.xm | 3d49d321365276a5 |
| Shareholding XBRL | 2024-06-30 | — | — | SHP_190316_1194636_19072024041817_WEB.xm | 56ede107209c1de1 |
| Shareholding XBRL | 2024-09-30 | — | — | SHP_192970_1278432_18102024055358_WEB.xm | 294557518df0f915 |
| Shareholding XBRL | 2024-12-31 | — | — | SHP_195073_1349012_17012025025839_WEB.xm | 3ba2010b4400e2db |
| Shareholding XBRL | 2025-03-31 | — | — | SHP_198690_1420964_21042025023117_WEB.xm | 9de60ae5708e4eb7 |
| Shareholding XBRL | 2025-06-30 | — | — | SHP_1514526_19082025110418_WEB.xml | 0716842250c1b8e4 |
| Shareholding XBRL | 2025-09-30 | — | — | SHP_1551721_17102025032408_WEB.xml | 8a6c0e6a1d6c6819 |
| Shareholding XBRL | 2025-12-31 | — | — | SHP_1605746_20012026045511_WEB.xml | 0952aada43a658e7 |
| Shareholding XBRL | 2026-03-31 | — | — | SHP_1654598_20042026115851_WEB.xml | 5dc85c1d6baf153a |
| Shareholding XBRL | 2026-06-30 | — | — | SHP_1697240_20072026060616_WEB.xml | 0afa4fd58ea0c54d |
| Related-party XBRL | 2022-09-30 | — | — | RPT_PPLPHARMA_22112022160848.xml | bb319ff1056f2a97 |
| Related-party XBRL | 2023-03-31 | — | — | RPT_851417_24052023110601_WEB.xml | 42127396f557f990 |
| Related-party XBRL | 2023-09-30 | — | — | RPT_969713_27102023103003_WEB.xml | fee50d4ace2bc422 |
| Related-party XBRL | 2024-03-31 | — | — | RPT_1120718_10052024085917_WEB.xml | 68211b1a030086da |
| Related-party XBRL | 2024-09-30 | — | — | RPT_1286523_23102024082258_WEB.xml | 790ab2a148149827 |